186 related articles for article (PubMed ID: 9032368)
1. Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant.
Nyambi PN; Lewi P; Peeters M; Janssens W; Heyndrickx L; Fransen K; Andries K; Vanden Haesevelde M; Heeney J; Piot P; van der Groen G
J Virol; 1997 Mar; 71(3):2320-30. PubMed ID: 9032368
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally.
Ondoa P; Davis D; Willems B; Heyndrickx L; Kestens L; van der Berg I; Coppens S; Janssens W; Heeney J; van der Groen G
J Med Virol; 2001 Dec; 65(4):765-76. PubMed ID: 11745943
[TBL] [Abstract][Full Text] [Related]
3. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
Kinsey NE; Anderson MG; Unangst TJ; Joag SV; Narayan O; Zink MC; Clements JE
Virology; 1996 Jul; 221(1):14-21. PubMed ID: 8661410
[TBL] [Abstract][Full Text] [Related]
4. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
Burns DP; Collignon C; Desrosiers RC
J Virol; 1993 Jul; 67(7):4104-13. PubMed ID: 8510218
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to V3 loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1ANT-70 isolate in human sera from different geographic regions.
Peeters M; Nkengasong J; Willems B; Karita E; Delaporte E; Van den Haesevelde M; Piot P; van der Groen G
AIDS; 1994 Dec; 8(12):1657-61. PubMed ID: 7888113
[TBL] [Abstract][Full Text] [Related]
6. SIVcpz from a naturally infected Cameroonian chimpanzee: biological and genetic comparison with HIV-1 N.
Müller-Trutwin MC; Corbet S; Souquière S; Roques P; Versmisse P; Ayouba A; Delarue S; Nerrienet E; Lewis J; Martin P; Simon F; Barré-Sinoussi F; Mauclère P
J Med Primatol; 2000 Aug; 29(3-4):166-72. PubMed ID: 11085579
[TBL] [Abstract][Full Text] [Related]
7. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque.
Glamann J; Burton DR; Parren PW; Ditzel HJ; Kent KA; Arnold C; Montefiori D; Hirsch VM
J Virol; 1998 Jan; 72(1):585-92. PubMed ID: 9420262
[TBL] [Abstract][Full Text] [Related]
8. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
[TBL] [Abstract][Full Text] [Related]
9. Persistent infection of macaques with simian-human immunodeficiency viruses.
Li JT; Halloran M; Lord CI; Watson A; Ranchalis J; Fung M; Letvin NL; Sodroski JG
J Virol; 1995 Nov; 69(11):7061-7. PubMed ID: 7474126
[TBL] [Abstract][Full Text] [Related]
10. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
Rybarczyk BJ; Montefiori D; Johnson PR; West A; Johnston RE; Swanstrom R
J Virol; 2004 Apr; 78(7):3561-71. PubMed ID: 15016879
[TBL] [Abstract][Full Text] [Related]
11. Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.
Barbian HJ; Decker JM; Bibollet-Ruche F; Galimidi RP; West AP; Learn GH; Parrish NF; Iyer SS; Li Y; Pace CS; Song R; Huang Y; Denny TN; Mouquet H; Martin L; Acharya P; Zhang B; Kwong PD; Mascola JR; Verrips CT; Strokappe NM; Rutten L; McCoy LE; Weiss RA; Brown CS; Jackson R; Silvestri G; Connors M; Burton DR; Shaw GM; Nussenzweig MC; Bjorkman PJ; Ho DD; Farzan M; Hahn BH
mBio; 2015 Apr; 6(2):. PubMed ID: 25900654
[TBL] [Abstract][Full Text] [Related]
12. Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.
Heeney JL; Rutjens E; Verschoor EJ; Niphuis H; ten Haaft P; Rouse S; McClure H; Balla-Jhagjhoorsingh S; Bogers W; Salas M; Cobb K; Kestens L; Davis D; van der Groen G; Courgnaud V; Peeters M; Murthy KK
J Virol; 2006 Jul; 80(14):7208-18. PubMed ID: 16809326
[TBL] [Abstract][Full Text] [Related]
13. Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.
Choi WS; Collignon C; Thiriart C; Burns DP; Stott EJ; Kent KA; Desrosiers RC
J Virol; 1994 Sep; 68(9):5395-402. PubMed ID: 7520089
[TBL] [Abstract][Full Text] [Related]
14. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence.
Burns DP; Desrosiers RC
Curr Top Microbiol Immunol; 1994; 188():185-219. PubMed ID: 7523031
[TBL] [Abstract][Full Text] [Related]
15. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.
Mossman SP; Bex F; Berglund P; Arthos J; O'Neil SP; Riley D; Maul DH; Bruck C; Momin P; Burny A; Fultz PN; Mullins JI; Liljeström P; Hoover EA
J Virol; 1996 Mar; 70(3):1953-60. PubMed ID: 8627721
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee.
Vanden Haesevelde MM; Peeters M; Jannes G; Janssens W; van der Groen G; Sharp PM; Saman E
Virology; 1996 Jul; 221(2):346-50. PubMed ID: 8661445
[TBL] [Abstract][Full Text] [Related]
17. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
[TBL] [Abstract][Full Text] [Related]
18. High-Resolution Sequencing of Viral Populations during Early Simian Immunodeficiency Virus Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.
Ita S; Hill AK; Lam EC; Dufort FJ; Yang X; Newman R; Leviyang S; Fofana IB; Johnson WE
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343575
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.
Etienne L; Nerrienet E; LeBreton M; Bibila GT; Foupouapouognigni Y; Rousset D; Nana A; Djoko CF; Tamoufe U; Aghokeng AF; Mpoudi-Ngole E; Delaporte E; Peeters M; Wolfe ND; Ayouba A
Retrovirology; 2011 Jan; 8():4. PubMed ID: 21232091
[TBL] [Abstract][Full Text] [Related]
20. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
